Azole Compounds as Inhibitors of Candida albicans: QSAR Modelling
Candida albicans is a pathogenic opportunistic yeast found in the human gut flora. It may also live outside of the human body, causing diseases ranging from minor to deadly. Candida albicans begins as a budding yeast that can become hyphae in response to a variety of environmental or biological trig...
Guardado en:
Autores principales: | Davood Gheidari, Morteza Mehrdad, Mahboubeh Ghahremani |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aa494da28fac413c9f62030b61fe0a76 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
QSAR based virtual screening derived identification of a novel hit as a SARS CoV-229E 3CLpro Inhibitor: GA-MLR QSAR modeling supported by molecular Docking, molecular dynamics simulation and MMGBSA calculation approaches
por: R.D. Jawarkar, et al.
Publicado: (2022) -
The antifungal effect of six commercial extracts of Chilean propolis on Candida spp
por: Herrera,Christian L, et al.
Publicado: (2010) -
Oxadiazole-Containing Macrocyclic Peptides Potentiate Azole Activity against Pathogenic <italic toggle="yes">Candida</italic> Species
por: Nicole M. Revie, et al.
Publicado: (2020) -
Caracterización de los mecanismos de resistencia a azoles en aislados clínicos chilenos de Candida albicans
por: Fuentes,Marisol, et al.
Publicado: (2014) -
Genetic Analysis of <italic toggle="yes">Candida auris</italic> Implicates Hsp90 in Morphogenesis and Azole Tolerance and Cdr1 in Azole Resistance
por: Sang Hu Kim, et al.
Publicado: (2019)